Pinnacle Bancorp’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-257
Closed -$11.1K 921
2025
Q1
$11.1K Buy
+257
New +$13K ﹤0.01% 681
2023
Q4
Sell
-337
Closed -$23K 814
2023
Q3
$23K Hold
337
0.01% 492
2023
Q2
$31.6K Hold
337
0.01% 442
2023
Q1
$22.9K Buy
+337
New +$21.7K 0.01% 477
2022
Q4
Sell
-133
Closed -$4K 748
2022
Q3
$4K Hold
133
﹤0.01% 654
2022
Q2
$5K Hold
133
﹤0.01% 653
2022
Q1
$9K Sell
133
-75
-36% -$5.48K ﹤0.01% 594
2021
Q4
$16K Buy
208
+111
+114% +$9.8K 0.01% 513
2021
Q3
$9K Buy
+97
New +$10.2K ﹤0.01% 605

Other funds holding EXAS

Pinnacle Bancorp's EXAS Position: Q2 2025 in Review

Pinnacle Bancorp sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 257 shares — an estimated $11.1K sold.

Pinnacle Bancorp first reported a position in EXAS in Q3 2021 and held it in 9 quarters. The position peaked at $31.6K in Q2 2023. 557 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Pinnacle Bancorp reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Pinnacle Bancorp sold 257 Exact Sciences shares in Q2 2025, an estimated $11.1K.
  • Pinnacle Bancorp first reported a position in Exact Sciences in Q3 2021 and held it in 9 quarters.
  • Pinnacle Bancorp's Exact Sciences position peaked at $31.6K in Q2 2023.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Pinnacle Bancorp's 13F filing for Q2 2025, filed 11 Jul 2025.